327 related articles for article (PubMed ID: 35012639)
1. Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease.
Fang J; Zhang P; Wang Q; Chiang CW; Zhou Y; Hou Y; Xu J; Chen R; Zhang B; Lewis SJ; Leverenz JB; Pieper AA; Li B; Li L; Cummings J; Cheng F
Alzheimers Res Ther; 2022 Jan; 14(1):7. PubMed ID: 35012639
[TBL] [Abstract][Full Text] [Related]
2. Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer's disease.
Xu J; Mao C; Hou Y; Luo Y; Binder JL; Zhou Y; Bekris LM; Shin J; Hu M; Wang F; Eng C; Oprea TI; Flanagan ME; Pieper AA; Cummings J; Leverenz JB; Cheng F
Cell Rep; 2022 Nov; 41(9):111717. PubMed ID: 36450252
[TBL] [Abstract][Full Text] [Related]
3. Multimodal single-cell/nucleus RNA sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer's disease.
Xu J; Zhang P; Huang Y; Zhou Y; Hou Y; Bekris LM; Lathia J; Chiang CW; Li L; Pieper AA; Leverenz JB; Cummings J; Cheng F
Genome Res; 2021 Oct; 31(10):1900-1912. PubMed ID: 33627474
[TBL] [Abstract][Full Text] [Related]
4. AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery.
Zhou Y; Fang J; Bekris LM; Kim YH; Pieper AA; Leverenz JB; Cummings J; Cheng F
Alzheimers Res Ther; 2021 Jan; 13(1):24. PubMed ID: 33441136
[TBL] [Abstract][Full Text] [Related]
5. Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing.
Fang J; Pieper AA; Nussinov R; Lee G; Bekris L; Leverenz JB; Cummings J; Cheng F
Med Res Rev; 2020 Nov; 40(6):2386-2426. PubMed ID: 32656864
[TBL] [Abstract][Full Text] [Related]
6. Artificial intelligence for drug discovery and development in Alzheimer's disease.
Qiu Y; Cheng F
Curr Opin Struct Biol; 2024 Apr; 85():102776. PubMed ID: 38335558
[TBL] [Abstract][Full Text] [Related]
7. Pathway-based integration of multi-omics data reveals lipidomics alterations validated in an Alzheimer's disease mouse model and risk loci carriers.
Garcia-Segura ME; Durainayagam BR; Liggi S; Graça G; Jimenez B; Dehghan A; Tzoulaki I; Karaman I; Elliott P; Griffin JL
J Neurochem; 2023 Jan; 164(1):57-76. PubMed ID: 36326588
[TBL] [Abstract][Full Text] [Related]
8. Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer's disease.
Jojo GM; Kuppusamy G
J Clin Pharm Ther; 2019 Jun; 44(3):337-348. PubMed ID: 30738020
[TBL] [Abstract][Full Text] [Related]
9. Identifying candidate genes and drug targets for Alzheimer's disease by an integrative network approach using genetic and brain region-specific proteomic data.
Liu A; Manuel AM; Dai Y; Fernandes BS; Enduru N; Jia P; Zhao Z
Hum Mol Genet; 2022 Sep; 31(19):3341-3354. PubMed ID: 35640139
[TBL] [Abstract][Full Text] [Related]
10. Combinational Drug Repurposing from Genetic Networks Applied to Alzheimer's Disease.
Nabirotchkin S; Bouaziz J; Glibert F; Mandel J; Foucquier J; Hajj R; Callizot N; Cholet N; Guedj M; Cohen D
J Alzheimers Dis; 2022; 88(4):1585-1603. PubMed ID: 35811522
[TBL] [Abstract][Full Text] [Related]
11. Deep post-GWAS analysis identifies potential risk genes and risk variants for Alzheimer's disease, providing new insights into its disease mechanisms.
Wang Z; Zhang Q; Lin JR; Jabalameli MR; Mitra J; Nguyen N; Zhang ZD
Sci Rep; 2021 Oct; 11(1):20511. PubMed ID: 34654853
[TBL] [Abstract][Full Text] [Related]
12. Association of type 2 diabetes GWAS loci and the risk of Parkinson's and Alzheimer's diseases.
Chung SJ; Kim MJ; Kim J; Ryu HS; Kim YJ; Kim SY; Lee JH
Parkinsonism Relat Disord; 2015 Dec; 21(12):1435-40. PubMed ID: 26499758
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome.
Chatterjee P; Roy D; Rathi N
J Alzheimers Dis; 2018; 61(1):53-65. PubMed ID: 29199645
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide network-based pathway analysis of CSF t-tau/Aβ1-42 ratio in the ADNI cohort.
Cong W; Meng X; Li J; Zhang Q; Chen F; Liu W; Wang Y; Cheng S; Yao X; Yan J; Kim S; Saykin AJ; Liang H; Shen L;
BMC Genomics; 2017 May; 18(1):421. PubMed ID: 28558704
[TBL] [Abstract][Full Text] [Related]
15. A Functional Pipeline of Genome-Wide Association Data Leads to Midostaurin as a Repurposed Drug for Alzheimer's Disease.
Esteban-Martos A; Brokate-Llanos AM; Real LM; Melgar-Locatelli S; de Rojas I; Castro-Zavala A; Bravo MJ; Mañas-Padilla MDC; García-González P; Ruiz-Galdon M; Pacheco-Sánchez B; Polvillo R; Rodriguez de Fonseca F; González I; Castilla-Ortega E; Muñoz MJ; Rivera P; Reyes-Engel A; Ruiz A; Royo JL
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569459
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the intercellular communication disruption and key pathways in Alzheimer's disease: an integrative study of single-nucleus transcriptomes and genetic association.
Liu A; Fernandes BS; Citu C; Zhao Z
Alzheimers Res Ther; 2024 Jan; 16(1):3. PubMed ID: 38167548
[TBL] [Abstract][Full Text] [Related]
17. Computational Drug Repurposing for Alzheimer's Disease Using Risk Genes From GWAS and Single-Cell RNA Sequencing Studies.
Xu Y; Kong J; Hu P
Front Pharmacol; 2021; 12():617537. PubMed ID: 34276354
[No Abstract] [Full Text] [Related]
18. Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes.
Hao K; Di Narzo AF; Ho L; Luo W; Li S; Chen R; Li T; Dubner L; Pasinetti GM
Mol Aspects Med; 2015; 43-44():66-76. PubMed ID: 26116273
[TBL] [Abstract][Full Text] [Related]
19. Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood.
Bourdakou MM; Fernández-Ginés R; Cuadrado A; Spyrou GM
Redox Biol; 2023 Nov; 67():102881. PubMed ID: 37696195
[TBL] [Abstract][Full Text] [Related]
20. Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer's disease.
Su WM; Gu XJ; Dou M; Duan QQ; Jiang Z; Yin KF; Cai WC; Cao B; Wang Y; Chen YP
J Neurol Neurosurg Psychiatry; 2023 Nov; 94(11):954-961. PubMed ID: 37349091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]